Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocol.

Quist-Paulsen P, Toft N, Heyman M, Abrahamsson J, Griškevičius L, Hallböök H, Jónsson ÓG, Palk K, Vaitkeviciene G, Vettenranta K, Åsberg A, Frandsen TL, Opdahl S, Marquart HV, Siitonen S, Osnes LT, Hultdin M, Overgaard UM, Wartiovaara-Kautto U, Schmiegelow K.

Leukemia. 2019 Oct 14. doi: 10.1038/s41375-019-0598-2. [Epub ahead of print]

PMID:
31611626
2.

Survival in adult acute lymphoblastic leukaemia (ALL): A report from the Swedish ALL Registry.

Lennmyr E, Karlsson K, Ahlberg L, Garelius H, Hulegårdh E, Izarra AS, Joelsson J, Kozlowski P, Moicean A, Tomaszewska-Toporska B, Lübking A, Hallböök H; Swedish Adult Acute Lymphoblastic Leukaemia Group (SVALL).

Eur J Haematol. 2019 Aug;103(2):88-98. doi: 10.1111/ejh.13247. Epub 2019 Jun 6.

PMID:
31074910
3.

Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).

Giebel S, Marks DI, Boissel N, Baron F, Chiaretti S, Ciceri F, Cornelissen JJ, Doubek M, Esteve J, Fielding A, Foa R, Gorin NC, Gökbuget N, Hallböök H, Hoelzer D, Paravichnikova E, Ribera JM, Savani B, Rijneveld AW, Schmid C, Wartiovaara-Kautto U, Mohty M, Nagler A, Dombret H.

Bone Marrow Transplant. 2019 Jun;54(6):798-809. doi: 10.1038/s41409-018-0373-4. Epub 2018 Nov 1. Review.

4.

A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia.

Enblad G, Karlsson H, Gammelgård G, Wenthe J, Lövgren T, Amini RM, Wikstrom KI, Essand M, Savoldo B, Hallböök H, Höglund M, Dotti G, Brenner MK, Hagberg H, Loskog A.

Clin Cancer Res. 2018 Dec 15;24(24):6185-6194. doi: 10.1158/1078-0432.CCR-18-0426. Epub 2018 Aug 10.

PMID:
30097433
5.

Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia.

Mogensen SS, Harila-Saari A, Mäkitie O, Myrberg IH, Niinimäki R, Vestli A, Hafsteinsdottir S, Griškevicius L, Saks K, Hallböök H, Retpen J, Helt LR, Toft N, Schmiegelow K, Frandsen TL; Nordic Society of Paediatric Haematology and Oncology (NOPHO) group.

Pediatr Blood Cancer. 2018 Oct;65(10):e27300. doi: 10.1002/pbc.27300. Epub 2018 Jun 26.

PMID:
29943905
6.

Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years.

Rank CU, Toft N, Tuckuviene R, Grell K, Nielsen OJ, Frandsen TL, Marquart HVH, Albertsen BK, Tedgård U, Hallböök H, Ruud E, Jarvis KB, Quist-Paulsen P, Huttunen P, Wartiovaara-Kautto U, Jónsson ÓG, Trakymiene SS, Griškevičius L, Saks K, Punab M, Schmiegelow K.

Blood. 2018 May 31;131(22):2475-2484. doi: 10.1182/blood-2018-01-827949. Epub 2018 Apr 16.

7.

Real-world data on first relapse of acute lymphoblastic leukemia in patients >55 years.

Lennmyr EB, Kozlowski P, Ahlberg L, Bernell P, Hulegårdh E, Izarra AS, Karlsson K, Tomaszewska-Toporska B, Åström M, Hallböök H; Swedish Adult Acute Lymphoblastic Leukemia Group, SVALL.

Leuk Lymphoma. 2018 Oct;59(10):2470-2473. doi: 10.1080/10428194.2017.1416369. Epub 2018 Jan 18. No abstract available.

PMID:
29345172
8.

Long-term outcome of Epstein-Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT.

Kinch A, Hallböök H, Arvidson J, Sällström K, Bondeson K, Pauksens K.

Leuk Lymphoma. 2018 May;59(5):1172-1179. doi: 10.1080/10428194.2017.1365860. Epub 2017 Aug 23.

PMID:
28831836
9.

Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia.

Toft N, Birgens H, Abrahamsson J, Griškevičius L, Hallböök H, Heyman M, Klausen TW, Jónsson ÓG, Palk K, Pruunsild K, Quist-Paulsen P, Vaitkeviciene G, Vettenranta K, Åsberg A, Frandsen TL, Marquart HV, Madsen HO, Norén-Nyström U, Schmiegelow K.

Leukemia. 2018 Mar;32(3):606-615. doi: 10.1038/leu.2017.265. Epub 2017 Aug 18.

PMID:
28819280
10.

Age but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden.

Kozlowski P, Lennmyr E, Ahlberg L, Bernell P, Hulegårdh E, Karbach H, Karlsson K, Tomaszewska-Toporska B, Åström M, Hallböök H; Swedish Adult Acute Lymphoblastic Leukemia Group (SVALL).

Eur J Haematol. 2017 Aug;99(2):141-149. doi: 10.1111/ejh.12896. Epub 2017 Jun 14.

11.

Ciprofloxacin prophylaxis delays initiation of broad-spectrum antibiotic therapy and reduces the overall use of antimicrobial agents during induction therapy for acute leukaemia: A single-centre study.

Hallböök H, Lidström AK, Pauksens K.

Infect Dis (Lond). 2016;48(6):443-8. doi: 10.3109/23744235.2016.1143963. Epub 2016 Feb 25.

PMID:
27030917
12.

Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.

Toft N, Birgens H, Abrahamsson J, Griškevičius L, Hallböök H, Heyman M, Klausen TW, Jónsson ÓG, Palk K, Pruunsild K, Quist-Paulsen P, Vaitkeviciene G, Vettenranta K, Asberg A, Helt LR, Frandsen T, Schmiegelow K.

Eur J Haematol. 2016 Feb;96(2):160-9. doi: 10.1111/ejh.12562. Epub 2015 Apr 24.

PMID:
25867866
13.

Satisfactory outcome after intensive chemotherapy with pragmatic use of minimal residual disease (MRD) monitoring in older patients with Philadelphia-negative B cell precursor acute lymphoblastic leukaemia: a Swedish registry-based study.

Bergfelt E, Kozlowski P, Ahlberg L, Hulegårdh E, Hägglund H, Karlsson K, Markuszewska-Kuczymska A, Tomaszewska-Toporska B, Smedmyr B, Åström M, Amini RM, Hallböök H.

Med Oncol. 2015 Apr;32(4):135. doi: 10.1007/s12032-015-0582-2. Epub 2015 Mar 22.

PMID:
25796502
14.

Outcome after HSCT in Philadelphia chromosome positive acute lymphoblastic leukemia in Sweden: a population-based study.

Hulegårdh E, Hägglund H, Ahlberg L, Karlsson K, Karbach H, Markuszewska A, Persson I, Åström M, Hallböök H.

Med Oncol. 2014 Aug;31(8):66. doi: 10.1007/s12032-014-0066-9. Epub 2014 Jun 26.

PMID:
24965535
15.

High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden.

Kozlowski P, Åström M, Ahlberg L, Bernell P, Hulegårdh E, Hägglund H, Karlsson K, Markuszewska-Kuczymska A, Tomaszewska-Toporska B, Smedmyr B, Amini RM, Hallböök H; Swedish Adult ALL Group.

Eur J Haematol. 2014;92(5):377-81. doi: 10.1111/ejh.12269. Epub 2014 Feb 21.

PMID:
24443846
16.

Complying with the European Clinical Trials directive while surviving the administrative pressure - an alternative approach to toxicity registration in a cancer trial.

Frandsen TL, Heyman M, Abrahamsson J, Vettenranta K, Åsberg A, Vaitkeviciene G, Pruunsild K, Toft N, Birgens H, Hallböök H, Quist-Paulsen P, Griškevičius L, Helt L, Hansen BV, Schmiegelow K.

Eur J Cancer. 2014 Jan;50(2):251-9. doi: 10.1016/j.ejca.2013.09.027. Epub 2013 Nov 11.

PMID:
24231337
17.

High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapse.

Machaczka M, Johansson JE, Remberger M, Hallböök H, Lazarevic VLj, Wahlin BE, Omar H, Wahlin A, Juliusson G, Kimby E, Hägglund H.

Med Oncol. 2013 Dec;30(4):762. doi: 10.1007/s12032-013-0762-x. Epub 2013 Nov 9.

PMID:
24214180
18.

Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol.

Toft N, Birgens H, Abrahamsson J, Bernell P, Griškevičius L, Hallböök H, Heyman M, Holm MS, Hulegårdh E, Klausen TW, Marquart HV, Jónsson OG, Nielsen OJ, Quist-Paulsen P, Taskinen M, Vaitkeviciene G, Vettenranta K, Åsberg A, Schmiegelow K.

Eur J Haematol. 2013 May;90(5):404-12. doi: 10.1111/ejh.12097. Epub 2013 Apr 2.

PMID:
23461707
19.

Parental age, family size, and offspring's risk of childhood and adult acute leukemia.

Larfors G, Hallböök H, Simonsson B.

Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1185-90. doi: 10.1158/1055-9965.EPI-12-0178. Epub 2012 Apr 26.

20.

Prophylactic platelet transfusions.

Pietersz RN, Reesink HW, Panzer S, Gilbertson MP, Borosak ME, Wood EM, Leitner GC, Rabitsch W, Ay C, Lambermont M, Deneys V, Sondag D, Compernolle V, Legrand D, François A, Tardivel R, Garban F, Sawant RB, Rebulla P, Handa M, Ohto H, Kerkhoffs JL, Brand A, Zhiburt E, Cid J, Escolar G, Lozano M, Puig L, Knutson F, Hallböök H, Lubenow N, Estcourt L, Stanworth S, Murphy MF, Williams L, Mraz DL, Ross RL, Snyder E.

Vox Sang. 2012 Aug;103(2):159-76. doi: 10.1111/j.1423-0410.2012.01595.x. Epub 2012 Apr 20. No abstract available.

PMID:
22519879
21.

High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003-2007.

Kozlowski P, Åström M, Ahlberg L, Bernell P, Hulegårdh E, Hägglund H, Karlsson K, Markuszewska-Kuczymska A, Tomaszewska-Toporska B, Smedmyr B, Hallböök H.

Haematologica. 2012 Sep;97(9):1414-21. doi: 10.3324/haematol.2011.057851. Epub 2012 Apr 17.

22.

Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?

Machaczka M, Johansson JE, Remberger M, Hallböök H, Malm C, Lazarevic VLj, Wahlin A, Omar H, Juliusson G, Kimby E, Hägglund H.

Leuk Lymphoma. 2012 Sep;53(9):1699-705. doi: 10.3109/10428194.2012.666661. Epub 2012 Mar 16.

PMID:
22335529
23.

The prophylactic use of granulocyte-colony stimulating factor during remission induction is associated with increased leukaemia-free survival of adults with acute lymphoblastic leukaemia: a joint analysis of five randomised trials on behalf of the EWALL.

Giebel S, Thomas X, Hallbook H, Geissler K, Boiron JM, Huguet F, Koller E, Jaeger U, Smedmyr B, Hellmann A, Holowiecki J.

Eur J Cancer. 2012 Feb;48(3):360-7. doi: 10.1016/j.ejca.2011.11.023. Epub 2011 Dec 22.

PMID:
22196969
24.

Myeloablative allogeneic stem cell transplantation for lymphoblastic lymphoma in Sweden: a retrospective study.

Lazarevic VLj, Remberger M, Hägglund H, Hallböök H, Juliusson G, Kimby E, Malm C, Wahlin A, Omar H, Johansson JE.

Am J Hematol. 2011 Aug;86(8):709-10. doi: 10.1002/ajh.22071. No abstract available.

25.

Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.

Juliusson G, Karlsson K, Lazarevic VLj, Wahlin A, Brune M, Antunovic P, Derolf A, Hägglund H, Karbach H, Lehmann S, Möllgård L, Stockelberg D, Hallböök H, Höglund M; Swedish Acute Leukemia Registry Group, the Swedish Acute Myeloid Leukemia Group, the Swedish Adult Acute Lymphoblastic Leukemia Group.

Cancer. 2011 Sep 15;117(18):4238-46. doi: 10.1002/cncr.26033. Epub 2011 Mar 8.

26.

Ex vivo activity of cardiac glycosides in acute leukaemia.

Hallböök H, Felth J, Eriksson A, Fryknäs M, Bohlin L, Larsson R, Gullbo J.

PLoS One. 2011 Jan 5;6(1):e15718. doi: 10.1371/journal.pone.0015718.

27.

Allogeneic haematopoietic stem-cell transplantation with reduced intensity conditioning for advanced stage Hodgkin's lymphoma in Sweden: high incidence of post transplant lymphoproliferative disorder.

Johansson JE, Remberger M, Lazarevic VLj, Hallböök H, Wahlin A, Kimby E, Juliusson G, Omar H, Hägglund H.

Bone Marrow Transplant. 2011 Jun;46(6):870-5. doi: 10.1038/bmt.2010.238. Epub 2010 Oct 18.

PMID:
20956959
28.

Long-term survival following allogeneic or syngeneic stem cell transplant for follicular lymphoma in Sweden.

Lazarevic VL, Hägglund H, Remberger M, Wahlin A, Hallböök H, Juliusson G, Kimby E, Malm C, Omar H, Johansson JE.

Leuk Lymphoma. 2011 Jan;52(1):69-71. doi: 10.3109/10428194.2010.520777. Epub 2010 Oct 4. No abstract available.

PMID:
20919855
29.

Population-based analyses in adult acute lymphoblastic leukemia.

Juliusson G, Karlsson K, Hallböök H.

Blood. 2010 Aug 12;116(6):1011; author reply 1012. doi: 10.1182/blood-2010-03-272724. No abstract available.

PMID:
20705768
30.

Does granulocyte colony-stimulating factor improve long-term outcome in adult acute lymphoblastic leukemia?

Hallböök H, Björkholm M, Hägglund H, Smedmyr B; Swedish Adult ALL Group.

Leuk Lymphoma. 2009 Nov;50(11):1872-4. doi: 10.3109/10428190903150821. No abstract available.

PMID:
19883315
31.

An investigation into whether deletions in 9p reflect prognosis in adult precursor B-cell acute lymphoblastic leukemia: a multi-center study of 381 patients.

Nahi H, Hägglund H, Ahlgren T, Bernell P, Hardling M, Karlsson K, Lazarevic VLj, Linderholm M, Smedmyr B, Aström M, Hallböök H.

Haematologica. 2008 Nov;93(11):1734-8. doi: 10.3324/haematol.13227. Epub 2008 Aug 25.

32.

U-2973, a novel B-cell line established from a patient with a mature B-cell leukemia displaying concurrent t(14;18) and MYC translocation to a non-IG gene partner.

Boström H, Leuchowius KJ, Hallböök H, Nordgren A, Thörn I, Thorselius M, Rosenquist R, Söderberg O, Sundström C.

Eur J Haematol. 2008 Sep;81(3):218-25. doi: 10.1111/j.1600-0609.2008.01098.x. Epub 2008 May 27.

PMID:
18510704
33.

Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol.

Hallböök H, Gustafsson G, Smedmyr B, Söderhäll S, Heyman M; Swedish Adult Acute Lymphocytic Leukemia Group; Swedish Childhood Leukemia Group.

Cancer. 2006 Oct 1;107(7):1551-61.

34.

In vitro activity of imatinib in cells from patients with adult acute lymphoblastic leukemia.

Hallböök H, Barbany G, Aleskog A, Björnberg A, Larsson R, Sundström C, Lindhagen E.

Anticancer Drugs. 2005 Jul;16(6):631-4.

PMID:
15930891
35.

Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience.

Hallböök H, Hägglund H, Stockelberg D, Nilsson PG, Karlsson K, Björkholm M, Linderholm M, Wahlin A, Linder O, Smedmyr B; Swedish Adult ALL Group.

Bone Marrow Transplant. 2005 Jun;35(12):1141-8.

PMID:
15834433
36.

High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia.

Hallböök H, Simonsson B, Ahlgren T, Björkholm M, Carneskog J, Grimfors G, Hast R, Karlsson K, Kimby E, Lerner R, Linder O, Linderholm M, Löfvenberg E, Malm C, Nilsson PG, Paul C, Stenke L, Stockelberg D, Tidefelt U, Turesson I, Uden-Blome AM, Vilen L, Wahlin A, Winquist I, Smedmyr B.

Br J Haematol. 2002 Sep;118(3):748-54.

PMID:
12181041

Supplemental Content

Loading ...
Support Center